NDMC 20mg

Jules Desmeules · Phase 1 active Small molecule Quality 0/100

At a glance

Generic name	NDMC 20mg
Sponsor	Jules Desmeules
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Evaluation of the Safety and Efficacy of N-desmethylclobazam in Patients With Peripheral Neuropathic Pain (PHASE2)
Exploring the Role of the GABAergic Modulation in Pain Transmission in Human (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

NDMC 20mg CI brief — competitive landscape report
NDMC 20mg updates RSS · CI watch RSS
Jules Desmeules portfolio CI